-
Golan will remain Syrian, vows President al-Sharaa at UN
-
Man Utd losses jump despite record revenues
-
Blueberry Strengthens MENA Presence with CMA Category 5 License and Dubai Office Launch
-
Ethiopia's Tigray rebels seize airports, clash with govt forces
-
Russia probes bear attacks, as official says town under 'siege'
-
China prodigy wins third Games gold as North Korea weightlifters roar
-
Robertson tells Spurs to 'forget' past woes
-
China's Yu, 13, wins third Asian Games gold but has 'some regrets'
-
Italy police find 3 million euros stashed in mobster's house
-
Oil falls, stocks steady as Trump hails 'good' Iran talks
-
Renard versus Queiroz in AFCON qualifying blockbuster
-
UK sets up unit to combat disinformation from Russia, AI
-
Former Mexico boss Aguirre returns to Spain with Valencia
-
ICC convicts C.Africa rebel leader
-
China swimmer, 13, seals Games hat-trick as North Korea win first gold
-
China's Yu, 13, wins third gold with latest Asian Games record
-
China's Xi heads to US for talks with Trump: state media
-
UK says will revisit Chagos deal after latest Trump criticism
-
Azerbaijan pardons Frenchman after EU lifts sanctions on oligarchs
-
In first, French presidential candidate gives birth during campaign
-
Hadjar extends Red Bull contract for 2027 F1 season
-
Cambodia no 'safe haven' for cyberscams, PM says
-
Black Sea drone attacks spell terror for Turkish sailors
-
North Korea weightlifter sets three world records for Asian Games gold
-
Canada judge to decide prison term for suicide poison seller
-
A Full Moon for Every Child: STARTRADER's STARCARES Brings Support to SOS Children's Village Ho Chi Minh City
-
Weinstein faces resentencing in New York for 2006 sex assault
-
Meta leans into AI, smart glasses amid privacy pushback
-
Outgoing UN chief makes climate push at New York summit
-
Battered Duerer masterpiece up for five-year revamp
-
AI risks, Iran war to take center stage at UN
-
Trump met with Venezuela's interim leader at UN
-
Badminton no.1 An tells dad to keep it down at Asian Games
-
Malaysia furore after Najib wins conditional house arrest
-
Runaway leader Antonelli eyeing third straight win
-
Italy hope for new dawn under Mancini
-
Schoolgirl Yu, 13, fastest again in bid for third Asian Games gold
-
Mongolian herders enlist new tech against harsher, drier climate
-
Oil prices fall after Trump hails 'good' talks with Iran
-
Tata turmoil shines light on India succession woes
-
AI political ads warp reality ahead of US midterms
-
World Cup 'not enough' as Spain begin next chapter
-
Kenneth Branagh embraces action hero role -- to get in shape
-
Meta acts against 3.7 mn scammers' accounts with Singapore police help
-
'New one' Klopp promises fresh approach as Germany reign begins
-
Australia PM says draft social media rules about taking back control
-
Milne returns to New Zealand squad for India T20 series
-
OMP and PwC Alliance Moves Process Manufacturers from Siloed Supply Chain Planning to Unified Decisions
-
SmartVendor Brings Autonomous Retail to the Czech Parliament; Clears Europe's Toughest Privacy Bar with SHEKEL WeightAI(TM)
-
Voting opens in Alaska's annual Fat Bear Week
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.
ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.
"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."
Solving the $1 million per study problem
While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.
This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.
Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.
The results are compelling:
Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.
$141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.
51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.
Shaping the Future of Study Operations
Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.
Site Identification & Feasibility
Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.
Study Startup
AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.
Remote Monitoring
AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.
Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.
Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.
All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025
Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/
About Florence Healthcare
Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.
Contact Information
Seema Sheth-Voss
[email protected]
(888) 829-0896
SOURCE: Florence Healthcare
View the original press release on ACCESS Newswire
J.Bergmann--BTB